Summary (tl;dr)

Former NBA player Jason Collins, renowned as the first openly gay athlete in a major American professional sports league, has publicly revealed his diagnosis of Stage 4 glioblastoma, an aggressive and rapidly progressing form of brain cancer.

Essential Background

Jason Collins played for 13 seasons in the NBA, retiring in 2014, and notably made history in 2013 as the first active male athlete in a major North American professional sport to come out as gay. In September 2025, his family released a vague statement indicating he was undergoing treatment for a brain tumor, with further details withheld to protect his privacy during a challenging time.

The Full Story

On December 11, 2025, Jason Collins shared the full details of his health battle in an interview with ESPN's Ramona Shelburne, confirming his diagnosis of Stage 4 glioblastoma. Collins reported experiencing concerning symptoms, including memory loss and difficulty concentrating, since August. These symptoms led him to undergo a CT scan at UCLA, where a "baseball-sized mass" was discovered in his brain, followed by a biopsy that confirmed the aggressive cancer. Due to the unresectable nature of his tumor and its resistance to standard chemotherapy, Collins is currently receiving targeted and experimental chemotherapy at a clinic in Singapore. He has expressed a determined outlook, viewing this fight as another opportunity to break barriers and potentially contribute to new treatment standards for others.

Why It Matters

This news is significant as it brings a high-profile figure's struggle with a deadly disease into the public eye, raising awareness about glioblastoma and the urgent need for advanced treatments. Collins's transparency, much like his historic coming out, offers a beacon of hope and support for others facing similar health challenges. His financial ability to pursue innovative international treatments also highlights disparities in healthcare access and the potential for his journey to pave the way for future medical advancements that could benefit a wider population.

Geographic Location

• UCLA Medical Center, Los Angeles, Los Angeles County, California, United States (initial CT scan and diagnosis)
• Singapore (undergoing targeted chemotherapy and innovative treatment)